1,853 followers
References: 1. https://t.co/nP4xy0elys 2. https://t.co/SALXMJR3CK
References: 1. https://t.co/nP4xy0elys 2. https://t.co/SALXMJR3CK
RT @CCR_AACR: Phase 2 Study Interim Analysis: Non-Inferiority Study of Doxorubicin and Upfront Dexrazoxane. https://t.co/lNLJKckcHJ https:…
Phase 2 Study Interim Analysis: Non-Inferiority Study of Doxorubicin and Upfront Dexrazoxane. https://t.co/lNLJKckcHJ https://t.co/NpFF17DqGi
Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma https://t.co/7wxKLEei6u